Loading…
Radiofrequency Ablation of Colorectal Liver Metastases: Small Size Favorably Predicts Technique Effectiveness and Survival
The objective of this study was to analyze long-term results of radiofrequency thermal ablation (RFA) for colorectal metastases (MTS), in order to evaluate predictors for adverse events, technique effectiveness, and survival. One hundred ninety-nine nonresectable MTS (0.5–8 cm; mean, 2.9 cm) in 122...
Saved in:
Published in: | Cardiovascular and interventional radiology 2008-09, Vol.31 (5), p.948-956 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c397t-80707debb974bbcb54e1d7401fc646e9a6d367644c4f19207e1770f6d4671e9e3 |
---|---|
cites | cdi_FETCH-LOGICAL-c397t-80707debb974bbcb54e1d7401fc646e9a6d367644c4f19207e1770f6d4671e9e3 |
container_end_page | 956 |
container_issue | 5 |
container_start_page | 948 |
container_title | Cardiovascular and interventional radiology |
container_volume | 31 |
creator | Veltri, Andrea Sacchetto, Paola Tosetti, Irene Pagano, Eva Fava, Cesare Gandini, Giovanni |
description | The objective of this study was to analyze long-term results of radiofrequency thermal ablation (RFA) for colorectal metastases (MTS), in order to evaluate predictors for adverse events, technique effectiveness, and survival. One hundred ninety-nine nonresectable MTS (0.5–8 cm; mean, 2.9 cm) in 122 patients underwent a total of 166 RFA sessions, percutaneously or during surgery. The technique was “simple” or “combined” with vascular occlusion. The mean follow-up time was 24.2 months. Complications, technique effectiveness, and survival rates were statistically analyzed. Adverse events occurred in 8.1% of lesions (major complication rate: 1.1%), 7.1% with simple and 16.7% with combined technique (
p
= 0.15). Early complete response was obtained in 151 lesions (81.2%), but 49 lesions (26.3%) recurred locally after a mean of 10.4 months. Sustained complete ablation was achieved in 66.7% of lesions ≤3 cm versus 33.3% of lesions >3 cm (
p
3 cm (
p
= 0.006). We conclude that “simple” RFA is safe and successful for MTS ≤3 cm, contributing to prolong survival when patients can be completely treated. |
doi_str_mv | 10.1007/s00270-008-9362-0 |
format | article |
fullrecord | <record><control><sourceid>proquest_osti_</sourceid><recordid>TN_cdi_osti_scitechconnect_21426348</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69541564</sourcerecordid><originalsourceid>FETCH-LOGICAL-c397t-80707debb974bbcb54e1d7401fc646e9a6d367644c4f19207e1770f6d4671e9e3</originalsourceid><addsrcrecordid>eNp1kVFrFDEUhQdR7Fr9Ab5IUPBt9N5MJpnxrSytCiuKW8G3kMnc0ZRsUpOZhe2vN2UXCoIQuIF85-RcTlW9RHiHAOp9BuAKaoCu7hvJa3hUrVA05dLJn4-rFaASNbYtnlXPcr4BwLbj7dPqDLsWZIv9qrr7bkYXp0R_Fgr2wC4Gb2YXA4sTW0cfE9nZeLZxe0rsC80ml0P5A9vujPds6-6IXZl9TGbwB_Yt0ejsnNk12d_BFU92OU3FosgD5cxMGNl2SXu3N_559WQyPtOL0zyvflxdXq8_1ZuvHz-vLza1bXo11x0oUCMNQ6_EMNihFYSjEoCTlUJSb-TYSCWFsGLCnoMiVAomOQqpkHpqzqs3R9-YZ6ezdXMJZ2MIJZfmKLhsRFeot0fqNsWSO89657Il702guGQt-1ZgK0UBX_8D3sQlhbKB5lw1giP2BcIjZFPMOdGkb5PbmXTQCPq-O33sTpfu9H13Gorm1cl4GXY0PihOZRWAH4FcnsIvSg8__9_1L1NspHo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>227342119</pqid></control><display><type>article</type><title>Radiofrequency Ablation of Colorectal Liver Metastases: Small Size Favorably Predicts Technique Effectiveness and Survival</title><source>Springer Nature</source><creator>Veltri, Andrea ; Sacchetto, Paola ; Tosetti, Irene ; Pagano, Eva ; Fava, Cesare ; Gandini, Giovanni</creator><creatorcontrib>Veltri, Andrea ; Sacchetto, Paola ; Tosetti, Irene ; Pagano, Eva ; Fava, Cesare ; Gandini, Giovanni</creatorcontrib><description>The objective of this study was to analyze long-term results of radiofrequency thermal ablation (RFA) for colorectal metastases (MTS), in order to evaluate predictors for adverse events, technique effectiveness, and survival. One hundred ninety-nine nonresectable MTS (0.5–8 cm; mean, 2.9 cm) in 122 patients underwent a total of 166 RFA sessions, percutaneously or during surgery. The technique was “simple” or “combined” with vascular occlusion. The mean follow-up time was 24.2 months. Complications, technique effectiveness, and survival rates were statistically analyzed. Adverse events occurred in 8.1% of lesions (major complication rate: 1.1%), 7.1% with simple and 16.7% with combined technique (
p
= 0.15). Early complete response was obtained in 151 lesions (81.2%), but 49 lesions (26.3%) recurred locally after a mean of 10.4 months. Sustained complete ablation was achieved in 66.7% of lesions ≤3 cm versus 33.3% of lesions >3 cm (
p
< 0.0001). Survival rates at 1, 3, and 5 years were 91%, 54%, and 33%, respectively, from the diagnosis of MTS and 79%, 38%, and 22%, respectively, from RFA. Mean survival time from RFA was 31.5 months, 36.2 in patients with main MTS ≤3 cm and 23.2 in those with at least one lesion >3 cm (
p
= 0.006). We conclude that “simple” RFA is safe and successful for MTS ≤3 cm, contributing to prolong survival when patients can be completely treated.</description><identifier>ISSN: 0174-1551</identifier><identifier>EISSN: 1432-086X</identifier><identifier>DOI: 10.1007/s00270-008-9362-0</identifier><identifier>PMID: 18506519</identifier><language>eng</language><publisher>New York: Springer-Verlag</publisher><subject>ABLATION ; Adenocarcinoma - mortality ; Adenocarcinoma - secondary ; Adenocarcinoma - therapy ; Adult ; Aged ; Aged, 80 and over ; Analysis of Variance ; BODY ; Cardiology ; Catheter Ablation - methods ; Chi-Square Distribution ; Clinical Investigation ; Cohort Studies ; Colorectal Neoplasms - mortality ; Colorectal Neoplasms - pathology ; Colorectal Neoplasms - therapy ; DIGESTIVE SYSTEM ; ELECTROMAGNETIC RADIATION ; Female ; Follow-Up Studies ; GLANDS ; Humans ; Imaging ; Kaplan-Meier Estimate ; LIVER ; Liver Neoplasms - mortality ; Liver Neoplasms - pathology ; Liver Neoplasms - secondary ; Liver Neoplasms - surgery ; Male ; MEDICINE ; Medicine & Public Health ; METASTASES ; Middle Aged ; Minimally Invasive Surgical Procedures - methods ; Multivariate Analysis ; Neoplasm Staging ; Nuclear Medicine ; ORGANS ; Predictive Value of Tests ; Quality of Life ; RADIATIONS ; Radiology ; RADIOLOGY AND NUCLEAR MEDICINE ; RADIOWAVE RADIATION ; Retrospective Studies ; Risk Assessment ; SURGERY ; Survival Analysis ; SURVIVAL TIME ; Treatment Outcome ; Ultrasound</subject><ispartof>Cardiovascular and interventional radiology, 2008-09, Vol.31 (5), p.948-956</ispartof><rights>Springer Science+Business Media, LLC 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c397t-80707debb974bbcb54e1d7401fc646e9a6d367644c4f19207e1770f6d4671e9e3</citedby><cites>FETCH-LOGICAL-c397t-80707debb974bbcb54e1d7401fc646e9a6d367644c4f19207e1770f6d4671e9e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18506519$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/21426348$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Veltri, Andrea</creatorcontrib><creatorcontrib>Sacchetto, Paola</creatorcontrib><creatorcontrib>Tosetti, Irene</creatorcontrib><creatorcontrib>Pagano, Eva</creatorcontrib><creatorcontrib>Fava, Cesare</creatorcontrib><creatorcontrib>Gandini, Giovanni</creatorcontrib><title>Radiofrequency Ablation of Colorectal Liver Metastases: Small Size Favorably Predicts Technique Effectiveness and Survival</title><title>Cardiovascular and interventional radiology</title><addtitle>Cardiovasc Intervent Radiol</addtitle><addtitle>Cardiovasc Intervent Radiol</addtitle><description>The objective of this study was to analyze long-term results of radiofrequency thermal ablation (RFA) for colorectal metastases (MTS), in order to evaluate predictors for adverse events, technique effectiveness, and survival. One hundred ninety-nine nonresectable MTS (0.5–8 cm; mean, 2.9 cm) in 122 patients underwent a total of 166 RFA sessions, percutaneously or during surgery. The technique was “simple” or “combined” with vascular occlusion. The mean follow-up time was 24.2 months. Complications, technique effectiveness, and survival rates were statistically analyzed. Adverse events occurred in 8.1% of lesions (major complication rate: 1.1%), 7.1% with simple and 16.7% with combined technique (
p
= 0.15). Early complete response was obtained in 151 lesions (81.2%), but 49 lesions (26.3%) recurred locally after a mean of 10.4 months. Sustained complete ablation was achieved in 66.7% of lesions ≤3 cm versus 33.3% of lesions >3 cm (
p
< 0.0001). Survival rates at 1, 3, and 5 years were 91%, 54%, and 33%, respectively, from the diagnosis of MTS and 79%, 38%, and 22%, respectively, from RFA. Mean survival time from RFA was 31.5 months, 36.2 in patients with main MTS ≤3 cm and 23.2 in those with at least one lesion >3 cm (
p
= 0.006). We conclude that “simple” RFA is safe and successful for MTS ≤3 cm, contributing to prolong survival when patients can be completely treated.</description><subject>ABLATION</subject><subject>Adenocarcinoma - mortality</subject><subject>Adenocarcinoma - secondary</subject><subject>Adenocarcinoma - therapy</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Analysis of Variance</subject><subject>BODY</subject><subject>Cardiology</subject><subject>Catheter Ablation - methods</subject><subject>Chi-Square Distribution</subject><subject>Clinical Investigation</subject><subject>Cohort Studies</subject><subject>Colorectal Neoplasms - mortality</subject><subject>Colorectal Neoplasms - pathology</subject><subject>Colorectal Neoplasms - therapy</subject><subject>DIGESTIVE SYSTEM</subject><subject>ELECTROMAGNETIC RADIATION</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>GLANDS</subject><subject>Humans</subject><subject>Imaging</subject><subject>Kaplan-Meier Estimate</subject><subject>LIVER</subject><subject>Liver Neoplasms - mortality</subject><subject>Liver Neoplasms - pathology</subject><subject>Liver Neoplasms - secondary</subject><subject>Liver Neoplasms - surgery</subject><subject>Male</subject><subject>MEDICINE</subject><subject>Medicine & Public Health</subject><subject>METASTASES</subject><subject>Middle Aged</subject><subject>Minimally Invasive Surgical Procedures - methods</subject><subject>Multivariate Analysis</subject><subject>Neoplasm Staging</subject><subject>Nuclear Medicine</subject><subject>ORGANS</subject><subject>Predictive Value of Tests</subject><subject>Quality of Life</subject><subject>RADIATIONS</subject><subject>Radiology</subject><subject>RADIOLOGY AND NUCLEAR MEDICINE</subject><subject>RADIOWAVE RADIATION</subject><subject>Retrospective Studies</subject><subject>Risk Assessment</subject><subject>SURGERY</subject><subject>Survival Analysis</subject><subject>SURVIVAL TIME</subject><subject>Treatment Outcome</subject><subject>Ultrasound</subject><issn>0174-1551</issn><issn>1432-086X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp1kVFrFDEUhQdR7Fr9Ab5IUPBt9N5MJpnxrSytCiuKW8G3kMnc0ZRsUpOZhe2vN2UXCoIQuIF85-RcTlW9RHiHAOp9BuAKaoCu7hvJa3hUrVA05dLJn4-rFaASNbYtnlXPcr4BwLbj7dPqDLsWZIv9qrr7bkYXp0R_Fgr2wC4Gb2YXA4sTW0cfE9nZeLZxe0rsC80ml0P5A9vujPds6-6IXZl9TGbwB_Yt0ejsnNk12d_BFU92OU3FosgD5cxMGNl2SXu3N_559WQyPtOL0zyvflxdXq8_1ZuvHz-vLza1bXo11x0oUCMNQ6_EMNihFYSjEoCTlUJSb-TYSCWFsGLCnoMiVAomOQqpkHpqzqs3R9-YZ6ezdXMJZ2MIJZfmKLhsRFeot0fqNsWSO89657Il702guGQt-1ZgK0UBX_8D3sQlhbKB5lw1giP2BcIjZFPMOdGkb5PbmXTQCPq-O33sTpfu9H13Gorm1cl4GXY0PihOZRWAH4FcnsIvSg8__9_1L1NspHo</recordid><startdate>20080901</startdate><enddate>20080901</enddate><creator>Veltri, Andrea</creator><creator>Sacchetto, Paola</creator><creator>Tosetti, Irene</creator><creator>Pagano, Eva</creator><creator>Fava, Cesare</creator><creator>Gandini, Giovanni</creator><general>Springer-Verlag</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>OTOTI</scope></search><sort><creationdate>20080901</creationdate><title>Radiofrequency Ablation of Colorectal Liver Metastases: Small Size Favorably Predicts Technique Effectiveness and Survival</title><author>Veltri, Andrea ; Sacchetto, Paola ; Tosetti, Irene ; Pagano, Eva ; Fava, Cesare ; Gandini, Giovanni</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c397t-80707debb974bbcb54e1d7401fc646e9a6d367644c4f19207e1770f6d4671e9e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>ABLATION</topic><topic>Adenocarcinoma - mortality</topic><topic>Adenocarcinoma - secondary</topic><topic>Adenocarcinoma - therapy</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Analysis of Variance</topic><topic>BODY</topic><topic>Cardiology</topic><topic>Catheter Ablation - methods</topic><topic>Chi-Square Distribution</topic><topic>Clinical Investigation</topic><topic>Cohort Studies</topic><topic>Colorectal Neoplasms - mortality</topic><topic>Colorectal Neoplasms - pathology</topic><topic>Colorectal Neoplasms - therapy</topic><topic>DIGESTIVE SYSTEM</topic><topic>ELECTROMAGNETIC RADIATION</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>GLANDS</topic><topic>Humans</topic><topic>Imaging</topic><topic>Kaplan-Meier Estimate</topic><topic>LIVER</topic><topic>Liver Neoplasms - mortality</topic><topic>Liver Neoplasms - pathology</topic><topic>Liver Neoplasms - secondary</topic><topic>Liver Neoplasms - surgery</topic><topic>Male</topic><topic>MEDICINE</topic><topic>Medicine & Public Health</topic><topic>METASTASES</topic><topic>Middle Aged</topic><topic>Minimally Invasive Surgical Procedures - methods</topic><topic>Multivariate Analysis</topic><topic>Neoplasm Staging</topic><topic>Nuclear Medicine</topic><topic>ORGANS</topic><topic>Predictive Value of Tests</topic><topic>Quality of Life</topic><topic>RADIATIONS</topic><topic>Radiology</topic><topic>RADIOLOGY AND NUCLEAR MEDICINE</topic><topic>RADIOWAVE RADIATION</topic><topic>Retrospective Studies</topic><topic>Risk Assessment</topic><topic>SURGERY</topic><topic>Survival Analysis</topic><topic>SURVIVAL TIME</topic><topic>Treatment Outcome</topic><topic>Ultrasound</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Veltri, Andrea</creatorcontrib><creatorcontrib>Sacchetto, Paola</creatorcontrib><creatorcontrib>Tosetti, Irene</creatorcontrib><creatorcontrib>Pagano, Eva</creatorcontrib><creatorcontrib>Fava, Cesare</creatorcontrib><creatorcontrib>Gandini, Giovanni</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Source</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>OSTI.GOV</collection><jtitle>Cardiovascular and interventional radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Veltri, Andrea</au><au>Sacchetto, Paola</au><au>Tosetti, Irene</au><au>Pagano, Eva</au><au>Fava, Cesare</au><au>Gandini, Giovanni</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Radiofrequency Ablation of Colorectal Liver Metastases: Small Size Favorably Predicts Technique Effectiveness and Survival</atitle><jtitle>Cardiovascular and interventional radiology</jtitle><stitle>Cardiovasc Intervent Radiol</stitle><addtitle>Cardiovasc Intervent Radiol</addtitle><date>2008-09-01</date><risdate>2008</risdate><volume>31</volume><issue>5</issue><spage>948</spage><epage>956</epage><pages>948-956</pages><issn>0174-1551</issn><eissn>1432-086X</eissn><abstract>The objective of this study was to analyze long-term results of radiofrequency thermal ablation (RFA) for colorectal metastases (MTS), in order to evaluate predictors for adverse events, technique effectiveness, and survival. One hundred ninety-nine nonresectable MTS (0.5–8 cm; mean, 2.9 cm) in 122 patients underwent a total of 166 RFA sessions, percutaneously or during surgery. The technique was “simple” or “combined” with vascular occlusion. The mean follow-up time was 24.2 months. Complications, technique effectiveness, and survival rates were statistically analyzed. Adverse events occurred in 8.1% of lesions (major complication rate: 1.1%), 7.1% with simple and 16.7% with combined technique (
p
= 0.15). Early complete response was obtained in 151 lesions (81.2%), but 49 lesions (26.3%) recurred locally after a mean of 10.4 months. Sustained complete ablation was achieved in 66.7% of lesions ≤3 cm versus 33.3% of lesions >3 cm (
p
< 0.0001). Survival rates at 1, 3, and 5 years were 91%, 54%, and 33%, respectively, from the diagnosis of MTS and 79%, 38%, and 22%, respectively, from RFA. Mean survival time from RFA was 31.5 months, 36.2 in patients with main MTS ≤3 cm and 23.2 in those with at least one lesion >3 cm (
p
= 0.006). We conclude that “simple” RFA is safe and successful for MTS ≤3 cm, contributing to prolong survival when patients can be completely treated.</abstract><cop>New York</cop><pub>Springer-Verlag</pub><pmid>18506519</pmid><doi>10.1007/s00270-008-9362-0</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0174-1551 |
ispartof | Cardiovascular and interventional radiology, 2008-09, Vol.31 (5), p.948-956 |
issn | 0174-1551 1432-086X |
language | eng |
recordid | cdi_osti_scitechconnect_21426348 |
source | Springer Nature |
subjects | ABLATION Adenocarcinoma - mortality Adenocarcinoma - secondary Adenocarcinoma - therapy Adult Aged Aged, 80 and over Analysis of Variance BODY Cardiology Catheter Ablation - methods Chi-Square Distribution Clinical Investigation Cohort Studies Colorectal Neoplasms - mortality Colorectal Neoplasms - pathology Colorectal Neoplasms - therapy DIGESTIVE SYSTEM ELECTROMAGNETIC RADIATION Female Follow-Up Studies GLANDS Humans Imaging Kaplan-Meier Estimate LIVER Liver Neoplasms - mortality Liver Neoplasms - pathology Liver Neoplasms - secondary Liver Neoplasms - surgery Male MEDICINE Medicine & Public Health METASTASES Middle Aged Minimally Invasive Surgical Procedures - methods Multivariate Analysis Neoplasm Staging Nuclear Medicine ORGANS Predictive Value of Tests Quality of Life RADIATIONS Radiology RADIOLOGY AND NUCLEAR MEDICINE RADIOWAVE RADIATION Retrospective Studies Risk Assessment SURGERY Survival Analysis SURVIVAL TIME Treatment Outcome Ultrasound |
title | Radiofrequency Ablation of Colorectal Liver Metastases: Small Size Favorably Predicts Technique Effectiveness and Survival |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T07%3A16%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Radiofrequency%20Ablation%20of%20Colorectal%20Liver%20Metastases:%20Small%20Size%20Favorably%20Predicts%20Technique%20Effectiveness%20and%20Survival&rft.jtitle=Cardiovascular%20and%20interventional%20radiology&rft.au=Veltri,%20Andrea&rft.date=2008-09-01&rft.volume=31&rft.issue=5&rft.spage=948&rft.epage=956&rft.pages=948-956&rft.issn=0174-1551&rft.eissn=1432-086X&rft_id=info:doi/10.1007/s00270-008-9362-0&rft_dat=%3Cproquest_osti_%3E69541564%3C/proquest_osti_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c397t-80707debb974bbcb54e1d7401fc646e9a6d367644c4f19207e1770f6d4671e9e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=227342119&rft_id=info:pmid/18506519&rfr_iscdi=true |